LifePoint Health (LPNT) Given Media Sentiment Rating of 0.45
Media coverage about LifePoint Health (NASDAQ:LPNT) has been trending positive recently, according to Accern Sentiment. The research group identifies negative and positive media coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. LifePoint Health earned a media sentiment score of 0.45 on Accern’s scale. Accern also gave news headlines about the company an impact score of 48.3303672685755 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.
Here are some of the headlines that may have impacted Accern’s analysis:
- $1.60 Billion in Sales Expected for LifePoint Health, Inc. (NASDAQ:LPNT) This Quarter (americanbankingnews.com)
- LifePoint Health, Inc. to Post FY2018 Earnings of $4.60 Per Share, Cantor Fitzgerald Forecasts (LPNT) (americanbankingnews.com)
- $0.96 Earnings Per Share Expected for LifePoint Health, Inc. (NASDAQ:LPNT) This Quarter (americanbankingnews.com)
- LifePoint Health, Inc. – Value Analysis (NASDAQ:LPNT) : August 7, 2017 (finance.yahoo.com)
- Q3 2017 Earnings Estimate for LifePoint Health, Inc. Issued By KeyCorp (NASDAQ:LPNT) (americanbankingnews.com)
Several brokerages recently weighed in on LPNT. BidaskClub downgraded shares of LifePoint Health from a “hold” rating to a “sell” rating in a research note on Tuesday, August 1st. Zacks Investment Research raised shares of LifePoint Health from a “hold” rating to a “buy” rating and set a $73.00 target price for the company in a research note on Thursday, July 13th. Royal Bank Of Canada reissued a “buy” rating and issued a $77.00 target price on shares of LifePoint Health in a research note on Wednesday, July 5th. Leerink Swann raised shares of LifePoint Health from a “market perform” rating to an “outperform” rating and boosted their target price for the company from $73.00 to $74.00 in a research note on Tuesday, June 6th. Finally, Morgan Stanley began coverage on shares of LifePoint Health in a research note on Tuesday, June 6th. They issued an “equal weight” rating and a $65.00 target price for the company. Three equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and five have given a buy rating to the company. LifePoint Health has a consensus rating of “Hold” and a consensus target price of $66.18.
LifePoint Health (NASDAQ LPNT) traded up 2.52% during mid-day trading on Friday, reaching $58.90. The company’s stock had a trading volume of 362,902 shares. LifePoint Health has a 1-year low of $50.60 and a 1-year high of $70.95. The firm has a 50-day moving average of $63.19 and a 200 day moving average of $62.78. The firm has a market capitalization of $2.36 billion, a price-to-earnings ratio of 13.19 and a beta of 0.86.
LifePoint Health (NASDAQ:LPNT) last announced its quarterly earnings data on Tuesday, August 1st. The company reported $0.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.06. The firm had revenue of $1.59 billion during the quarter, compared to the consensus estimate of $1.64 billion. LifePoint Health had a return on equity of 7.52% and a net margin of 2.88%. The business’s revenue for the quarter was up .2% on a year-over-year basis. During the same period in the prior year, the business earned $0.69 EPS. Equities analysts expect that LifePoint Health will post $4.07 earnings per share for the current year.
In other LifePoint Health news, Chairman William F. Carpenter III sold 17,653 shares of the company’s stock in a transaction dated Monday, July 17th. The stock was sold at an average price of $65.06, for a total value of $1,148,504.18. Following the transaction, the chairman now directly owns 439,841 shares of the company’s stock, valued at approximately $28,616,055.46. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Chairman William F. Carpenter III sold 82,347 shares of the company’s stock in a transaction dated Thursday, June 15th. The stock was sold at an average price of $64.15, for a total value of $5,282,560.05. Following the completion of the transaction, the chairman now directly owns 504,535 shares in the company, valued at $32,365,920.25. The disclosure for this sale can be found here. 7.28% of the stock is currently owned by corporate insiders.
About LifePoint Health
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.
Receive News & Ratings for LifePoint Health Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.